Should FDA Supervise and Carry Out Clinical Trials?

...assuming the Agency were staffed and funded to do this (a huge assumption) couldn't this be the solution to all the Vytorin-esque situations that have come up lately? Is the temptation to "cheat" just too strong for an industry that's under such strong pressure to show financial results? So asks Emil Ciurczak in his latest column. Click here to read more.